EQT agrees $2.1bn take-private for Swedish pharma business Recipharm
Private equity house EQT has agreed a $2.1bn take-private deal for Swedish pharmaceutical business Recipharm.
Private equity house EQT has agreed a $2.1bn take-private deal for Swedish pharmaceutical business Recipharm.
Recent Comments